Table 2 Multivariate analysis of the value of ezrin, maspin and nm23‐H1 protein expressions in predicting patients' outcome.
Variables | DFS | ||
---|---|---|---|
RR | 95% CI | p Value | |
Model 1 | |||
T category: T1–2/T3–4 | 0.528 | 0.276 to 1.009 | 0.053 |
N category: N0/N1–3 | 0.409 | 0.208 to 0.806 | 0.0097 |
Maspin: absent or present | 0.552 | 0.297 to 1.027 | 0.06 |
Model 2 | |||
T category: T1–2/T3–4 | 0.59 | 0.306 to 1.138 | 0.11 |
N category: N0/N1–3 | 0.356 | 0.17 to 0.717 | 0.0039 |
Ezrin: absent or present | 0.266 | 0.63 to 1.111 | 0.069 |
Model 3 | |||
T category: T1–2/T3–4 | 0.61 | 0.316 to 1.117 | 0.14 |
N category: N0/N1–3 | 0.337 | 0.167 to 0.68 | 0.0024 |
nm23‐H1: absent or present | 0.961 | 0.524 to 1.765 | 0.899 |
DFS, disease‐free survival; N, nodal status; T, tumour size.
All models have been constructed by stratifying by histological grade (1 v 2–3)